Males in good general health 50 years of age and older, with symptoms of moderate to severe benign prostatic hyperplasia.~120 patients: Study arm- min. 80 patients Placebo arm- min. 40 patients Final Aim for Stat. Sig.: 75% of recruitment group (90 patients)~Duration - 12 weeks with 3 visits: 0,6,12 weeks~The following procedures are utilized:~Physical exams - visit 1,3.~Drugs/food supplement usage questionnaire - visit 1.~Product supply Control - visit 1,2.3~Clinical laboratory tests : psa, cbc, bun - visit 1,3.~Uroflowmetry test visit - visit 1,3.~IPSS- International Prostate Symptom Score - questionnaire - visit 1, 3.~IIEF questionnaire - visit 1, 3.~dosage: 1 capsule twice daily (morning & evening) can be taken with or without food
A randomized, placebo controlled double-blind, 12-week treatment trial in men with moderate to severe symptoms of benign prostatic hyperplasia. The trail is about to examine the effect of Brizo® on reduction of BPH related symptoms.